Year: 2009
Type: dissertation
Abstract: Stavudine, a nucleoside reverse transcriptase inhibitor (NRTI) used to treat \ninfection by the human immunodeficiency virus (HIV), causes peripheral \nneuropathy and pain in HIV-positive patients. The mechanisms of this toxic \nneuropathy are poorly understood, partly because of a lack of animal models of the \ndisease process. I investigated whether long-term daily oral administration of \nstavudine affects nociception in Sprague-Dawley rats, and whether changes in \nnociception are accompanied by a general deterioration in the rats’ conditions, as \nreflected in activity and appetite. Daily stavudine administration induced \nmechanical hyperalgesia in rats within three weeks without affecting appetite, \ngrowth or physical activity, and this hyperalgesia persisted throughout the six \nweeks of stavudine administration. I then investigated whether central changes \nunderlie the hyperalgesia caused by stavudine in rats by examining inflammatory \ncytokine secretion and neuronal death in the spinal cord. Daily stavudine \nadministration caused an increase in cytokine-induced neutrophil chemo-attractant \n(CINC)-1 concentration in the spinal cord after six weeks, but early development of \nstavudine-induced hyperalgesia did not depend on increases in spinal concentrations \nof CINC-1 and interleukin (IL)-6, nor on apoptosis or necrosis of spinal neurones. \nThe neurotoxicity of stavudine is thought to derive from mitochondrial toxicity, \nwhich has been linked to increased plasma lactate concentration and decreased \nplasma adiponectin levels caused by lipodystrophy. Thus, I investigated whether a \nsystemic inflammatory response or metabolic dysregulation accompanied stavudine-induced hypernociception by examining plasma adiponectin, lactate, \nCINC-1 and IL-6 concentrations in rats administered daily stavudine. Plasma \nadiponectin, lactate, CINC-1 and IL-6 concentrations were unchanged following \nthree or six weeks of daily stavudine administration. Therefore, I have shown that \nstavudine-induced hyperalgesia is not dependent on spinal cord plasticity, nor on a \nsystemic inflammatory response or extensive metabolic malfunction. Instead, the \nhyperalgesia I observed may be caused by the adverse effects of stavudine on \nperipheral neurone functioning. As stavudine administration to healthy rats had no \nadverse effects besides inducing hyperalgesia and causing a rise in CINC-1 \nconcentration in the spinal cord after six weeks, my results indicate that many other \nside effects commonly associated with stavudine treatment in HIV-positive patients \nmay arise through interaction with the underlying HIV infection.
Author: Juliane Weber
Institution: University of the Witwatersrand
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2244998028
